Taselisib (GDC 0032)
Taselisib (GDC 0032, RG7604) is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | S7103 |
| Sku # | S7103-10mM/1mL |
| Pricing | 10mM/1mL, $127.00 |
Citations for this product:
-
bioRxiv - Cancer Biology 2020Quote: Drugs that were used to treat cells include taselisib (Selleck Chemicals # S7103), alpelisib (Selleck Chemicals # S2814) ...
-
bioRxiv - Pathology 2021Quote: ... or Taselisib 1 µM (S7103, Selleck Chemicals Llc) either alone or in combination using the D300e digital dispenser (Tecan Group ...